
Regional Medical Scientific Director, Cardiopulmonary & Pulmonary Hypertension -- Mid-Atlantic Territory
Merck
Summary
The Regional Medical Scientific Director | Cardiopulmonary & Pulmonary Hypertension is a credentialed (MD, PhD, PharmD or APP) therapeutic and disease area expert in Pulmonary Hypertension who engages in scientific exchange and research support with external scientific leaders and investigators.
Job description
Key Functions
- Identify, establish and manage collaborative professional relationships with national, regional and clinical practice scientific leaders (SLs) and investigators to address scientific needs and ensure access to medical and scientific information on areas of therapeutic interest.
- Conduct peer-level scientific discussions and maintain a reliable presence to ensure Scientific Leaders have a Research & Development Division/Medical Affairs contact.
- Engage in proactive non-product discussions regarding scientific issues (e.g., disease states, diagnosis, epidemiology, unmet medical need, population health).
- Facilitate appropriate scientific exchange of information with SLs, integrating scientific knowledge with actionable insights.
- Communicate external stakeholder opinions, insights and feedback on new data, clinical trends and the evolving medical landscape to Medical Affairs HQ teams.
- Represent the Research & Development Division at scientific meetings and congresses and contribute to debriefs, insight discussions and post congress reports.
- Support data generation activities including the Investigator Study Program (ISP) by acting as primary liaison to investigators.
- Identify potential investigators for participation in phase II-IV clinical development programs and provide scientific support for sponsored trials.
- Provide in-depth scientific support to Health Systems Teams.
- Demonstrate and maintain in-depth knowledge of the assigned disease and therapeutic area(s) through educational efforts, conferences, workshops, and journal review.
- Fully comply with all company policies and applicable laws, regulations, and ethical standards.
Education
M.D., Ph.D., Pharm.D. or APP relevant to the Pulmonary Hypertension area are requirements of the position.
Requirements
- M.D., Ph.D., Pharm.D. or APP relevant to the Pulmonary Hypertension area
- Three years in the biotech/pharmaceutical or healthcare environment
- Three years clinical and/or research in Cardiovascular & Pulmonary therapeutic areas with demonstrated scientific excellence, or five years of Medical Scientific Liaison (MSL) in relevant therapeutic areas
- Principled interpersonal, communication, networking, and presentation skills
- Deep therapeutic competency in Cardiovascular & Pulmonary/translational science areas
- Ability to network and partner with external customers including scientific leaders, investigators, clinical practice leaders, academic institutions, and treatment guideline members
- Must reside within Virginia, Maryland, or Washington D.C.
Benefits
- Medical, Dental & Vision
- 401(k) Matching
- Retirement Benefits
- Paid Holidays
- Vacation
- Compassionate Leave
- Sick Days
- Annual Bonus
- Long-Term Incentive
Company overview
Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.